1st May 2024 07:00
Haleon plc: 2024 Q1 Trading Statement
1 May 2024: Haleon plc's Q1 trading update for the year ended 31 December 2024 is available at: http://www.rns-pdf.londonstockexchange.com/rns/7006M_1-2024-4-30.pdf.
The Q1 trading statement will also be available on the Haleon website www.haleon.com/investors, and the statement has been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Presentation for analysts and shareholders:
A short presentation followed by Q&A will be hosted by Tobias Hestler, Chief Financial Officer and Sonya Ghobrial, Head of Investor Relations at 9:00am BST (10:00am CEST) on 1 May 2024, which can be accessed at www.haleon.com/investors.
For analysts and shareholders wishing to ask questions on the Q&A call, please use the dial-in details below which will have a Q&A facility:
UK: | +44 800 279 3956 |
US: | +1 866 291 4166 |
All other: | +44 (0) 207 107 0613 |
Passcode: | 43700369 |
An archived webcast of the Q&A call will be available later on the day of the results and can be accessed at www.haleon.com/investors.
Enquiries |
| ||
|
| ||
Investors | Media
| ||
Sonya Ghobrial | +44 7392 784784 | Zoë Bird | +44 7736 746167 |
Rakesh Patel | +44 7552 484646 | Nidaa Lone | +44 7841 400607 |
Emma White | +44 7823 523562 | ||
Email: [email protected] |
Email: [email protected] |
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.
Related Shares:
Haleon